Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Kidney Cancer treatment details. Chemotherapy. Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Survival: 7.5 months
Toxicity Grade: 3
Treatments: Chemotherapy
Country: United States
City/State/Province: New York, New York
Hospital: Memorial Sloan-Kettering Cancer Center
Journal: Link
Date: 9/2004

Patients: This Phase II study involved 37 patients with advanced renal cell carcinoma, 26 men and 11 women. The median age was 64. Twenty-three patients had undergone prior nephrectomy.

Treatment: The treatment consisted of administration of a new chemotherapy agent, Bortezomib.

Toxicity: Grade 3 toxicities included constipation, dehydration, diarrhea, dyspnea, fatigue, hypercalcemeia, ileus,infection, insomnia, nausea, neuropathy, rash, and hematologic.

Results: Median survival was 7.5 months.

Correspondence: Robert Motzer, MD

E-mail to a Friend Email Physician More Information